ASIC approves C3 name change
By Dylan Bushell-Embling
Tuesday, 17 June, 2008
Tuesday, 17 June, 2008
The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.
The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.
Related News
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
